A&D Pharma targets Serbia and former Yugoslavian countries for expansion

Romania-based A&D Pharma Maketing&Sales, a division of the pharma company A&D Pharma, plans to expand its activity on markets like Serbia and the former Yugoslavian countries, according to Robert Popescu, the company's executive manager. The division, which runs marketing, sales and promotion activities, has previously bought similar companies in Bulgaria, Poland, Hungary, Slovakia and the Czech Republic, for some EUR 19.1 million. “We operate in six countries. There are still countries in the area where we could do business, for example Serbia and the former Yugoslavian countries. These are close to use, and countries where there are most likely opportunities worth checking. For the time being we are cautious with the former Soviet Union countries. We are actually discussing the possibility to extend some contract we have to countries where we are not yet present,” said Popescu, quoted by wall-street.ro. Founded in 1994, A&D Pharma owns Romania’s pharmaceutical wholesale, sales and marketing services network “Mediplus”, and Romania’s largest national branded chain of pharmacies “Sensiblu”. The group’s consolidated sales increased by an annual rate of 34 percent between 2003 and 2009, amounting to EUR 514.3 million for the twelve months ending on 31 December 2009. A&D Pharma’s shares have been traded in the form of Global Depositary Receipts (“GDRs”) on the regulated market of the London Stock Exchange since October 2006 under the symbol ‘ADPH‘, but the company has recently decided to delist its shares from the London Stock Exchange. editor@romania-insider.com